TOP

Products
Products

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Our competent advice, comprehensive services, and effective tools and resources guide your risk management decisions.

Learn More

Claims

Our team of expert claim professionals develop effective claims management strategies specific to our clients’ needs.

Learn More

Market Research & Surveys

We produce marketplace surveys for our clients and the insurance industry. Clients also benefit from our individualized services including business monitoring.

Learn More

Analytics

We have a global network of data scientists, and deep expertise in solving complex business problems.

Learn More

Recent Research

Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim
The Gen Re Dread Disease Survey – Key Takeaways for Mainland China Market [Infographic]
The 8th edition of our Dread Disease Survey (2015–2020) for the Mainland China market was completed earlier this year. Here we provide an overview of the key findings and their implications for the Critical Illness (CI) business.
Samuel Lim
Ups and Downs of the U.S. Group Term Life Market
Gen Re’s 2023 U.S. Group Term Life Market Survey was released to participating companies this spring – providing an overall picture of the $34 billion market. The analysis of the reported data paints a stable market picture overall, although outliers in some segments influence the apparent trend.
Michael Turner
Actuarial Insights on Heat-Related Mortality and Morbidity
Optimal temperatures for health vary by region. Adapting behaviours and environments can reduce heat-related deaths. We explore actuarial insights into how rising global temperatures are increasing heat-related mortality and morbidity, and the significant implications for the insurance industry.
Sarah Hogekamp
An Overview of Mitral Regurgitation Heart Valve Disorder – and Underwriting Considerations
Mitral regurgitation is the second most common form of valvular heart disease after aortic stenosis, with a similar prevalence in men and women. Here’s a detailed overview of the complex but common valve disorder, with some key points to consider in your underwriting practices.
Gary Kranich

Find an Expert in Your Region